Vampt America, Inc.

CIK:0001365022|SEC Filings

Basis of Presentation and Nature of Operations (Tables)

9 Months Ended

Sep. 30, 2012

Basis Of Presentation and Nature Of Operations [Abstract]

Schedule of net assets at estimated fair market value

Cash	$	47,425
Current liabilities	$	21,308
Net assets acquired	$	26,117

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating Activities
Net loss	$ (2,906,021)	$ (1,178,299)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of deferred financing cost	21,462
Gain on derivative liability	(2,061)
Stock option expense	712,988
Loss on extinguishment of debt	457,777
Write-down of excess inventory	14,017
Amortization of debt discount	31,157
Common stock issued for services	186,790
Changes in operating assets and liabilities:
Accounts receivable	(27,406)	3,360
Inventory	90,351	(292,272)
Prepaid expenses and deposits	(73,701)
Accounts payable – related party		1,366,109
Accounts payable and accrued liabilities	204,567	48,775
Net cash used for operating activities	(1,290,080)	(52,327)
Investing Activities
Cash acquired in Coronado acquisition	47,425
Net cash provided by investing activities	47,425
Financing Activities
Bank overdraft		22,401
Advances from (repayments to) related party	(103,824)	(347,500)
Repayment of notes payable	(77,116)
Proceeds from the issuance of debt	848,782	377,426
Proceeds from the issuance of related party debt	195,581
Payment on related party debt	(68,503)
Payment of financing fees	(49,070)
Proceeds from sale of common stock	493,062
Net cash provided by financing activities	1,238,912	52,327
Increase (decrease) in cash and cash equivalents	(3,743)
Cash and cash equivalents, beginning of period	13,469
Cash and cash equivalents, end of period	9,726
Supplementary cash flow information:
Cash paid on interest	41,701	6,226
Non-cash items:
Debt discount on warrants issued with debt	12,449
Debt discount from derivative liability	10,504
Reclassification of debt to accrued liabilities	27,158
Common stock issued for acquisition of Coronado Corp.	$ 26,117

Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current
Cash and cash equivalents	$ 9,726	$ 13,469
Accounts receivable	55,180	27,774
Inventories, net	151,305	255,674
Prepaid expenses and deposits	85,001	11,300
Total current assets	301,212	308,217
Deferred financing costs	27,608
Total Assets	328,820	308,217
Current
Accounts payable and accrued liabilities	770,126	529,954
Short term related party debt	128,939
Short term convertible notes payable, net	567,948	34,121
Derivative liability	8,443
Due to stockholder	650,356	754,180
Total Current liabilities	2,125,812	1,318,255
Long term convertible notes payable, net	323,157
Long term notes payable	508,885	602,158
Total Liabilities	2,957,854	1,920,413
Stockholders’ equity (deficit)
Capital StockAuthorized: 100,000,000 common share, $0.001 par value Issued and outstanding shares: 24,439,830 and 1, respectively September 30, 2012 and December 31, 2011	24,440
Series A Preferred StockAuthorized: 200,000,000 preferred shares, $0.001 par value Issued and outstanding shares: 100 and 0, respectively September 30, 2012 and December 31, 2011
Additional paid in capital	2,159,642	1
Capital stock subscribed, but unissued		294,898
Deficit	(4,813,116)	(1,907,095)
Total stockholders’ deficit	(2,629,034)	(1,612,196)
Total Liability and Stockholders’ Deficit	$ 328,820	$ 308,217